Stockreport

Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]

Protagenic Therapeutics, Inc.  (PTIX) 
US:NASDAQ Investor Relations: protagenic.com/investors
PDF Phase 1/2a trial, designed to assess both healthy volunteers and patients diagnosed with Treatment-Resistant Depression, PTSD or Generalized Anxiety Disorder, progressi [Read more]